Related Experiment Videos
Statin therapy in patients with chronic kidney disease: to use or not to use
O M Steinmetz1, U Panzer, R A K Stahl
1Department of Medicine, Division of Nephrology, University Hospital of Hamburg Eppendorf, Hamburg, Germany.
Abstract:
Dyslipdemia is a common complication of chronic kidney disease (CKD) and contributes to high cardiovascular morbidity and mortality of CKD patients. Experimental studies have demonstrated that lipids induce glomerular and tubulointerstitial injury and that lipid-lowering treatments ameliorate renal injury. Therapy with statins not only has the potential to lower cardiovascular morbidity and mortality in patients with CKD but also to slow progression of renal disease. Whereas the guidelines for treatment of hyperlipidaemia in nonrenal patients are based on prospective, randomized, placebo-controlled mega-trials, such data are not available for CKD patients. This review outlines the limited information currently available on the effect of statins among patients with CKD and summarizes the ongoing randomized trials designed to address this question.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant